rs147405067

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The NM_004252.5(NHERF1):​c.-43C>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0138 in 1,531,540 control chromosomes in the GnomAD database, including 190 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.0079 ( 10 hom., cov: 33)
Exomes 𝑓: 0.014 ( 180 hom. )

Consequence

NHERF1
NM_004252.5 5_prime_UTR

Scores

2

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.204

Publications

1 publications found
Variant links:
Genes affected
NHERF1 (HGNC:11075): (NHERF family PDZ scaffold protein 1) This gene encodes a sodium/hydrogen exchanger regulatory cofactor. The protein interacts with and regulates various proteins including the cystic fibrosis transmembrane conductance regulator and G-protein coupled receptors such as the beta2-adrenergic receptor and the parathyroid hormone 1 receptor. The protein also interacts with proteins that function as linkers between integral membrane and cytoskeletal proteins. The protein localizes to actin-rich structures including membrane ruffles, microvilli, and filopodia. Mutations in this gene result in hypophosphatemic nephrolithiasis/osteoporosis type 2, and loss of heterozygosity of this gene is implicated in breast cancer.[provided by RefSeq, Sep 2009]
SLC9A3R1-AS1 (HGNC:55322): (SLC9A3R1 antisense RNA 1)
MIR3615 (HGNC:38905): (microRNA 3615) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 17-74748804-C-A is Benign according to our data. Variant chr17-74748804-C-A is described in ClinVar as Likely_benign. ClinVar VariationId is 1316123.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00787 (1198/152272) while in subpopulation SAS AF = 0.0188 (91/4830). AF 95% confidence interval is 0.0157. There are 10 homozygotes in GnomAd4. There are 542 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 1198 AD,Unknown gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004252.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NHERF1
NM_004252.5
MANE Select
c.-43C>A
5_prime_UTR
Exon 1 of 6NP_004243.1O14745-1
SLC9A3R1-AS1
NR_187307.1
n.929G>T
non_coding_transcript_exon
Exon 2 of 3
MIR3615
NR_037409.1
n.*105C>A
downstream_gene
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NHERF1
ENST00000262613.10
TSL:1 MANE Select
c.-43C>A
5_prime_UTR
Exon 1 of 6ENSP00000262613.5O14745-1
NHERF1
ENST00000851804.1
c.-43C>A
5_prime_UTR
Exon 1 of 7ENSP00000521863.1
NHERF1
ENST00000851803.1
c.-43C>A
5_prime_UTR
Exon 1 of 6ENSP00000521862.1

Frequencies

GnomAD3 genomes
AF:
0.00787
AC:
1197
AN:
152154
Hom.:
10
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00256
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00478
Gnomad ASJ
AF:
0.00519
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.0186
Gnomad FIN
AF:
0.00226
Gnomad MID
AF:
0.00318
Gnomad NFE
AF:
0.0128
Gnomad OTH
AF:
0.00573
GnomAD2 exomes
AF:
0.0104
AC:
1712
AN:
164426
AF XY:
0.0115
show subpopulations
Gnomad AFR exome
AF:
0.00290
Gnomad AMR exome
AF:
0.00574
Gnomad ASJ exome
AF:
0.00524
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00247
Gnomad NFE exome
AF:
0.0134
Gnomad OTH exome
AF:
0.00881
GnomAD4 exome
AF:
0.0144
AC:
19909
AN:
1379268
Hom.:
180
Cov.:
27
AF XY:
0.0147
AC XY:
10070
AN XY:
684374
show subpopulations
African (AFR)
AF:
0.00223
AC:
72
AN:
32288
American (AMR)
AF:
0.00591
AC:
227
AN:
38378
Ashkenazi Jewish (ASJ)
AF:
0.00629
AC:
158
AN:
25108
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37956
South Asian (SAS)
AF:
0.0200
AC:
1618
AN:
81028
European-Finnish (FIN)
AF:
0.00307
AC:
108
AN:
35146
Middle Eastern (MID)
AF:
0.00783
AC:
44
AN:
5622
European-Non Finnish (NFE)
AF:
0.0160
AC:
17074
AN:
1066032
Other (OTH)
AF:
0.0105
AC:
608
AN:
57710
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.513
Heterozygous variant carriers
0
999
1998
2998
3997
4996
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
692
1384
2076
2768
3460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00787
AC:
1198
AN:
152272
Hom.:
10
Cov.:
33
AF XY:
0.00728
AC XY:
542
AN XY:
74456
show subpopulations
African (AFR)
AF:
0.00255
AC:
106
AN:
41568
American (AMR)
AF:
0.00483
AC:
74
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00519
AC:
18
AN:
3470
East Asian (EAS)
AF:
0.000194
AC:
1
AN:
5160
South Asian (SAS)
AF:
0.0188
AC:
91
AN:
4830
European-Finnish (FIN)
AF:
0.00226
AC:
24
AN:
10622
Middle Eastern (MID)
AF:
0.00342
AC:
1
AN:
292
European-Non Finnish (NFE)
AF:
0.0128
AC:
871
AN:
67996
Other (OTH)
AF:
0.00567
AC:
12
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
62
123
185
246
308
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00864
Hom.:
2
Bravo
AF:
0.00779
Asia WGS
AF:
0.00635
AC:
22
AN:
3478

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.75
CADD
Benign
7.2
DANN
Benign
0.84
PhyloP100
-0.20
PromoterAI
0.095
Neutral
Mutation Taster
=300/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs147405067; hg19: chr17-72744943; API